The Ergomed team is excited to exhibit at the World Orphan Drug Congress Europe 2022 in Sitges, Spain, from 14-17 of November.
The World Orphan Drug Congress Europe is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.
This year, the World Orphan Drug Congress Europe, together with the co-located Cell & Gene Therapy Congress, will continue to bring experts from the whole value chain under one roof.
COVID has accelerated the use of innovations in Rare Disease Drug Development. Learn which innovations are having a meaningful impact.
We invite you to visit Egomed booth #60 to meet our expert Zizi Imatorbhebhe, together with the commercial team, to learn how Ergomed Clinical Research expertise and solution can help with your advanced therapies clinical development trial.
We also encourage you to join us and listen to Zizi Imatorbhebhe as she speaks on “Adopting Innovations for Rare Disease Drug Development” on Wednesday, November 16, 2022, from 2:10 PM to 2:40 PM (30 min.) at Clinical Development — Room 1.
Zizi Imatorbhebhe, MBA, MS, PMP®
Senior Vice President, Global Strategy and Development,
Head Rare Disease Innovation Center
Marie-Edith Bonneterre, MD, MBA
Senior Vice President, Global Medical Affairs
Ethel Vissers
Senior Vice President, Global Business Development
ethel.vissers@ergomedgroup.com
Prashant Desai
Senior Director, Business Development
prashant.desai@ergomedgroup.com
Kamel Boumali
Senior Director, Business Development
kamel.boumali@ergomedgroup.com
For more information about this event, visit The World Orphan Drug Congress Europe 2022 agenda.
To set up a meeting with Ergomed team during the World Orphan Drug Congress Europe, reserve a slot!
If you have any questions you can email us at marketing@ergomedgroup.com.
